Latest News and Press Releases

LONDON, Feb. 22, 2019 (GLOBE NEWSWIRE) -- ReNeuron’s (RENE) announcement of early but exciting data on three patients in the clinical study of its human retinal progenitor cell (hRPC) product was...

LONDON, Feb. 14, 2019 (GLOBE NEWSWIRE) -- InMed (IN) recently reported results for the second quarter of FY19 and is on track to bring INM-750 for epidermolysis bullosa (EB) into the clinic by the...

LONDON, Jan. 24, 2019 (GLOBE NEWSWIRE) -- ReNeuron has announced the long-awaited dosing of the first patient in its placebo-controlled US Phase IIb (PISCES III) study in patients six to 12 months...

The key findings for the latest mining report from Edison Investment Research are: Many commodities show in-situ value accretion when moving projects from inferred through to measured resources,...

LONDON, Jan. 22, 2019 (GLOBE NEWSWIRE) -- 1Spatial’s (SPA) transition plan appears to be on track. Recent contract wins, US trends and mobile solutions should both sustain growth and ensure it...

LONDON, Dec. 21, 2018 (GLOBE NEWSWIRE) -- ReNeuron’s (RENE) H119 results highlighted cash of £30.7m, allowing it to execute on its ongoing clinical trials, although execution will bring a funding...

LONDON, Dec. 20, 2018 (GLOBE NEWSWIRE) -- Following a challenging first half, Cohort (CHRT) has seen excellent order intake in recent months. These underpin anticipated sales for H219 and provide...

LONDON, Dec. 10, 2018 (GLOBE NEWSWIRE) -- ADL Bionatur Solutions (ADL-BS) was formed through the reverse takeover in April 2018 of contract manufacturing (CMO) and active pharmaceutical ingredient...

LONDON, Dec. 07, 2018 (GLOBE NEWSWIRE) -- Atossa Genetics’s (ATOS) endoxifen programs are advancing in their respective breast health programs. The firm recently reported positive safety data from...

LONDON, Dec. 04, 2018 (GLOBE NEWSWIRE) -- International Stem Cell (ISCO) reported Q318 revenues of $3.2m, up 73.0% compared to Q317 mainly due to the biomedical business, which had quarterly...